Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2020 | Launching a self-administration service during the COVID-19 pandemic

Lisa Barrot • 20 Nov 2020
UKONS 2020
General Bortezomib Cytarabine Denosumab Trastuzumab

Lisa Barrot, BSc, Ba, MSc, PhD, The Royal Marsden NHS Foundation Trust, London, UK, outlines the process of launching a self-administration service at the Royal Marsden NHS Foundation Trust, during the ongoing COVID-19 pandemic and associated challenges. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Lisa Barrot

Cancer nursing response to COVID-19
4:13
Cancer nursing response to COVID-19
Lisa Barrot • 20 Nov 2020

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals